Target intelligence / Profile preview

Zinc finger and BTB domain containing 12B, pseudogene (ZBTB12BP)

Target: ZBTB12BP
Molecular classification: Other, Pseudogene

Overview

Zinc finger and BTB domain containing 12B, pseudogene (ZBTB12BP) is classified as a pseudogene in humans[2][4]. It is not known to encode a functional protein and does not serve as a receptor, enzyme, transporter, or transcription factor. Instead, it is considered a genomic sequence related to protein-coding genes in the zinc finger and BTB domain-containing family but lacks protein expression or established biological function[2][4]. No roles in disease, drug interactions, or therapeutic targeting have been reported for this pseudogene.

Other names: ZBTB12BZBTB12P1ZNF920

Beyond the preview

Go deeper on Zinc finger and BTB domain containing 12B, pseudogene (ZBTB12BP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger and BTB domain containing 12B, pseudogene (ZBTB12BP).

Explore the full profile